1 MONTELUKAST SODIUM | 150 of 1080 | 2880 prescriptions Less than 1% of all prescriptions | 1900 | 790 patients 23% of all patients | 610 patients 18% of all patients | |
2 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 230 of 1110 | 2010 prescriptions Less than 1% of all prescriptions | 1430 | 570 patients 17% of all patients | 420 patients 12% of all patients | |
3 FLUTICASONE PROPIONATE | 80 of 990 | 1870 prescriptions Less than 1% of all prescriptions | 1010 | 660 patients 19% of all patients | 470 patients 14% of all patients | |
4 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 120 of 920 | 1370 prescriptions Less than 1% of all prescriptions | 770 | 380 patients 11% of all patients | 240 patients 7% of all patients | |
5 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 350 of 1080 | 1430 prescriptions Less than 1% of all prescriptions | 1040 | 360 patients 10% of all patients | < 11 | |
6 SPIRIVA (TIOTROPIUM BROMIDE) | 110 of 1020 | 1330 prescriptions Less than 1% of all prescriptions | 1120 | 270 patients 8% of all patients | < 11 | |
7 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 180 of 1030 | 1320 prescriptions Less than 1% of all prescriptions | 1070 | 360 patients 10% of all patients | < 11 | |
8 VENTOLIN HFA (ALBUTEROL SULFATE) | 270 of 1160 | 1470 prescriptions Less than 1% of all prescriptions | 660 | 560 patients 16% of all patients | 350 patients 10% of all patients | |
9 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 190 of 960 | 1060 prescriptions Less than 1% of all prescriptions | 820 | 230 patients 7% of all patients | < 11 | |
10 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 360 of 1050 | 710 prescriptions Less than 1% of all prescriptions | 350 | 180 patients 5% of all patients | < 11 | |
11 STIOLTO RESPIMAT (TIOTROPIUM BR/OLODATEROL HCL) | 160 of 580 | 610 prescriptions Less than 1% of all prescriptions | 470 | 160 patients 5% of all patients | < 11 | |
12 PREDNISONE | 450 of 1180 | 1220 prescriptions Less than 1% of all prescriptions | 1040 | 780 patients 23% of all patients | 650 patients 19% of all patients | |
13 PROAIR HFA (ALBUTEROL SULFATE) | 430 of 1110 | 810 prescriptions Less than 1% of all prescriptions | 490 | 360 patients 10% of all patients | < 11 | |
14 AZITHROMYCIN | 250 of 920 | 690 prescriptions Less than 1% of all prescriptions | | 350 patients 10% of all patients | < 11 | A |
15 OMEPRAZOLE | 430 of 690 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 DULERA (MOMETASONE/FORMOTEROL) | 130 of 370 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 310 of 620 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 BEVESPI AEROSPHERE (GLYCOPYRROLATE/FORMOTEROL FUM) | 120 of 300 | 220 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
19 TRAZODONE HCL | 160 of 290 | 210 prescriptions Less than 1% of all prescriptions | 210 | < 11 | < 11 | |
20 ELIQUIS (APIXABAN) | 160 of 200 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
21 THEOPHYLLINE (THEOPHYLLINE ANHYDROUS) | 120 of 180 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 320 of 550 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
23 ADVAIR HFA (FLUTICASONE PROPION/SALMETEROL) | 290 of 550 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 ROPINIROLE HCL | 170 of 310 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
25 LEVOFLOXACIN | 110 of 580 | 430 prescriptions Less than 1% of all prescriptions | | 380 patients 11% of all patients | < 11 | A |
26 SILDENAFIL (SILDENAFIL CITRATE) | 130 of 180 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
27 DOXYCYCLINE HYCLATE | 120 of 390 | 320 prescriptions Less than 1% of all prescriptions | | 270 patients 8% of all patients | < 11 | A |
28 CEFDINIR | 50 of 160 | 230 prescriptions Less than 1% of all prescriptions | | 190 patients 6% of all patients | < 11 | A |